Quality standards for safe medication in nursing homes: development through a multistep approach including a Delphi consensus study

被引:2
作者
Bruhwiler, Lea Domenica [1 ]
Niederhauser, Andrea [1 ]
Fischer, Simone [1 ]
Schwappach, David L. B. [1 ,2 ]
机构
[1] Swiss Patient Safety Fdn, Zurich, Switzerland
[2] Univ Bern, Inst Social & Prevent Med ISPM, Bern, Switzerland
来源
BMJ OPEN | 2021年 / 11卷 / 10期
关键词
geriatric medicine; quality in health care; health & safety; ADVERSE DRUG EVENTS; POLYPHARMACY; CARE; INTERVENTIONS; CRITERIA; OUTCOMES;
D O I
10.1136/bmjopen-2021-054364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aim of the study was to develop quality standards reflecting minimal requirements for safe medication processes in nursing homes. Design In a first step, relevant key topics for safe medication processes were deducted from a systematic search for similar guidelines, prior work and discussions with experts. In a second step, the essential requirements for each key topic were specified and substantiated with a literature-based rationale. Subsequently, the requirements were evaluated with a piloted, two-round Delphi study. Setting Nursing homes in Switzerland. Participants Interprofessional panel of 25 experts from science and practice. Primary and secondary outcome measures Each requirement was rated for its relevance for a safer and resident-oriented medication on a 9-point Likert-Scale based on the RAND/UCLA method. The requirements were considered relevant if, in the second round, the median relevance rating was >= 7 and the proportion of ratings >= 7 was >= 80%. Results Five key topics with a total of 87 requirements were elaborated and rated in the Delphi study. After the second round (response rate in both rounds 100%), 85 requirements fulfilled the predefined criteria and were therefore included in the final set of quality standards. The five key topics are: (I) 'The medication is reviewed regularly and in defined situations', (II) 'The medication is reviewed in a structured manner', (III) 'The medication is monitored in a structured manner', (IV) 'All healthcare professionals are committed to an optimal interprofessional collaboration' and (V) 'Residents are actively involved in medication process'. Conclusions We developed normative quality standards for a safer and resident-oriented medication in Swiss nursing homes. Altogether, 85 requirements define the medication processes and the behaviour of healthcare professionals. A rigorous implementation may support nursing homes in taking a step towards safer and resident-oriented medication.
引用
收藏
页数:8
相关论文
共 35 条
  • [1] Ten-Year Trend in Polypharmacy in the Lausanne Population
    Abolhassani, Nazanin
    Vollenweider, Peter
    Waeber, Gerard
    Marques-Vidal, Pedro
    [J]. JOURNAL OF PATIENT SAFETY, 2021, 17 (04) : E269 - E273
  • [2] Comprehensive Literature Review of Factors Influencing Medication Safety in Nursing Homes: Using a Systems Model
    Al-Jumaili, Ali Azeez
    Doucette, William R.
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2017, 18 (06) : 470 - 488
  • [3] Interventions to optimise prescribing for older people in care homes
    Alldred, David P.
    Kennedy, Mary-Claire
    Hughes, Carmel
    Chen, Timothy F.
    Miller, Paul
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [4] [Anonymous], 2017, DTSCH GESELLSCHAFT A
  • [5] [Anonymous], 2011, GUID PHARM PROV RES
  • [6] [Anonymous], 2014, HAUSARZTLICHE LEITLI
  • [7] Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators: A Systematic Review
    Boulkedid, Rym
    Abdoul, Hendy
    Loustau, Marine
    Sibony, Olivier
    Alberti, Corinne
    [J]. PLOS ONE, 2011, 6 (06):
  • [8] Bruhwiler L., 2019, ZUSAMMENFASSUNG ARZT
  • [9] Bruhwiler L., 2018, ESCP S BELF
  • [10] Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial
    Cateau, Damien
    Ballabeni, Pierluigi
    Niquille, Anne
    [J]. BMC GERIATRICS, 2021, 21 (01)